nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—Misoprostol—PTGER4—multiple sclerosis	0.0495	0.781	CrCbGaD
Lubiprostone—CBR1—Azacitidine—Cladribine—multiple sclerosis	0.0218	1	CbGdCrCtD
Lubiprostone—CLCN2—spinal cord—multiple sclerosis	0.0208	0.203	CbGeAlD
Lubiprostone—CLCN2—cerebellum—multiple sclerosis	0.0165	0.161	CbGeAlD
Lubiprostone—Dinoprostone—PTGER4—multiple sclerosis	0.0139	0.219	CrCbGaD
Lubiprostone—CLCN2—brain—multiple sclerosis	0.0134	0.13	CbGeAlD
Lubiprostone—CBR1—medulla oblongata—multiple sclerosis	0.00937	0.0911	CbGeAlD
Lubiprostone—CBR1—midbrain—multiple sclerosis	0.00856	0.0832	CbGeAlD
Lubiprostone—CBR1—spinal cord—multiple sclerosis	0.00835	0.0812	CbGeAlD
Lubiprostone—CBR1—nervous system—multiple sclerosis	0.00704	0.0684	CbGeAlD
Lubiprostone—CBR1—central nervous system—multiple sclerosis	0.00678	0.0659	CbGeAlD
Lubiprostone—CBR1—cerebellum—multiple sclerosis	0.00662	0.0644	CbGeAlD
Lubiprostone—CBR1—brain—multiple sclerosis	0.00538	0.0523	CbGeAlD
Lubiprostone—Oedema—Mitoxantrone—multiple sclerosis	0.00213	0.00262	CcSEcCtD
Lubiprostone—Shock—Mitoxantrone—multiple sclerosis	0.0021	0.00258	CcSEcCtD
Lubiprostone—Abdominal pain—Azathioprine—multiple sclerosis	0.00208	0.00257	CcSEcCtD
Lubiprostone—Tachycardia—Mitoxantrone—multiple sclerosis	0.00208	0.00256	CcSEcCtD
Lubiprostone—Skin disorder—Mitoxantrone—multiple sclerosis	0.00207	0.00255	CcSEcCtD
Lubiprostone—Vomiting—Cladribine—multiple sclerosis	0.00206	0.00254	CcSEcCtD
Lubiprostone—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00206	0.00254	CcSEcCtD
Lubiprostone—Rash—Cladribine—multiple sclerosis	0.00204	0.00252	CcSEcCtD
Lubiprostone—Dermatitis—Cladribine—multiple sclerosis	0.00204	0.00251	CcSEcCtD
Lubiprostone—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.00203	0.00251	CcSEcCtD
Lubiprostone—Weight increased—Prednisone—multiple sclerosis	0.00203	0.0025	CcSEcCtD
Lubiprostone—Anorexia—Mitoxantrone—multiple sclerosis	0.00203	0.0025	CcSEcCtD
Lubiprostone—Headache—Cladribine—multiple sclerosis	0.00203	0.0025	CcSEcCtD
Lubiprostone—Ill-defined disorder—Prednisolone—multiple sclerosis	0.00199	0.00245	CcSEcCtD
Lubiprostone—Mental disorder—Methylprednisolone—multiple sclerosis	0.00198	0.00244	CcSEcCtD
Lubiprostone—Erythema—Triamcinolone—multiple sclerosis	0.00197	0.00243	CcSEcCtD
Lubiprostone—Malnutrition—Methylprednisolone—multiple sclerosis	0.00196	0.00242	CcSEcCtD
Lubiprostone—Erythema—Methylprednisolone—multiple sclerosis	0.00196	0.00242	CcSEcCtD
Lubiprostone—Hypersensitivity—Azathioprine—multiple sclerosis	0.00194	0.00239	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.00194	0.00239	CcSEcCtD
Lubiprostone—Malaise—Prednisolone—multiple sclerosis	0.00193	0.00238	CcSEcCtD
Lubiprostone—Dysgeusia—Triamcinolone—multiple sclerosis	0.00193	0.00237	CcSEcCtD
Lubiprostone—Nausea—Cladribine—multiple sclerosis	0.00192	0.00237	CcSEcCtD
Lubiprostone—Syncope—Prednisolone—multiple sclerosis	0.00192	0.00237	CcSEcCtD
Lubiprostone—Dyspnoea—Mitoxantrone—multiple sclerosis	0.0019	0.00234	CcSEcCtD
Lubiprostone—Loss of consciousness—Prednisolone—multiple sclerosis	0.00188	0.00232	CcSEcCtD
Lubiprostone—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00187	0.00231	CcSEcCtD
Lubiprostone—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00185	0.00228	CcSEcCtD
Lubiprostone—Fatigue—Mitoxantrone—multiple sclerosis	0.00184	0.00226	CcSEcCtD
Lubiprostone—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.00183	0.00225	CcSEcCtD
Lubiprostone—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.00182	0.00225	CcSEcCtD
Lubiprostone—Constipation—Mitoxantrone—multiple sclerosis	0.00182	0.00224	CcSEcCtD
Lubiprostone—Pain—Mitoxantrone—multiple sclerosis	0.00182	0.00224	CcSEcCtD
Lubiprostone—Diarrhoea—Azathioprine—multiple sclerosis	0.0018	0.00222	CcSEcCtD
Lubiprostone—Discomfort—Prednisolone—multiple sclerosis	0.0018	0.00222	CcSEcCtD
Lubiprostone—Abdominal discomfort—Methotrexate—multiple sclerosis	0.00179	0.0022	CcSEcCtD
Lubiprostone—Erythema—Dexamethasone—multiple sclerosis	0.00179	0.0022	CcSEcCtD
Lubiprostone—Erythema—Betamethasone—multiple sclerosis	0.00179	0.0022	CcSEcCtD
Lubiprostone—Malaise—Triamcinolone—multiple sclerosis	0.00178	0.00219	CcSEcCtD
Lubiprostone—Malaise—Methylprednisolone—multiple sclerosis	0.00177	0.00218	CcSEcCtD
Lubiprostone—Syncope—Triamcinolone—multiple sclerosis	0.00177	0.00217	CcSEcCtD
Lubiprostone—Syncope—Methylprednisolone—multiple sclerosis	0.00176	0.00217	CcSEcCtD
Lubiprostone—Connective tissue disorder—Prednisone—multiple sclerosis	0.00176	0.00216	CcSEcCtD
Lubiprostone—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00176	0.00216	CcSEcCtD
Lubiprostone—Oedema—Prednisolone—multiple sclerosis	0.00175	0.00215	CcSEcCtD
Lubiprostone—Dizziness—Azathioprine—multiple sclerosis	0.00174	0.00215	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00174	0.00215	CcSEcCtD
Lubiprostone—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00173	0.00213	CcSEcCtD
Lubiprostone—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.00173	0.00213	CcSEcCtD
Lubiprostone—Shock—Prednisolone—multiple sclerosis	0.00172	0.00212	CcSEcCtD
Lubiprostone—Cough—Triamcinolone—multiple sclerosis	0.00172	0.00212	CcSEcCtD
Lubiprostone—Tachycardia—Prednisolone—multiple sclerosis	0.00171	0.0021	CcSEcCtD
Lubiprostone—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00169	0.00208	CcSEcCtD
Lubiprostone—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00168	0.00207	CcSEcCtD
Lubiprostone—Myalgia—Triamcinolone—multiple sclerosis	0.00168	0.00206	CcSEcCtD
Lubiprostone—Vomiting—Azathioprine—multiple sclerosis	0.00168	0.00206	CcSEcCtD
Lubiprostone—Myalgia—Methylprednisolone—multiple sclerosis	0.00167	0.00206	CcSEcCtD
Lubiprostone—Anxiety—Methylprednisolone—multiple sclerosis	0.00167	0.00205	CcSEcCtD
Lubiprostone—Rash—Azathioprine—multiple sclerosis	0.00166	0.00205	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00166	0.00205	CcSEcCtD
Lubiprostone—Dermatitis—Azathioprine—multiple sclerosis	0.00166	0.00204	CcSEcCtD
Lubiprostone—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00166	0.00204	CcSEcCtD
Lubiprostone—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00166	0.00204	CcSEcCtD
Lubiprostone—Discomfort—Triamcinolone—multiple sclerosis	0.00166	0.00204	CcSEcCtD
Lubiprostone—Discomfort—Methylprednisolone—multiple sclerosis	0.00165	0.00204	CcSEcCtD
Lubiprostone—Headache—Azathioprine—multiple sclerosis	0.00165	0.00203	CcSEcCtD
Lubiprostone—Dry mouth—Triamcinolone—multiple sclerosis	0.00164	0.00202	CcSEcCtD
Lubiprostone—Malaise—Betamethasone—multiple sclerosis	0.00161	0.00198	CcSEcCtD
Lubiprostone—Malaise—Dexamethasone—multiple sclerosis	0.00161	0.00198	CcSEcCtD
Lubiprostone—Oedema—Triamcinolone—multiple sclerosis	0.00161	0.00198	CcSEcCtD
Lubiprostone—Syncope—Dexamethasone—multiple sclerosis	0.0016	0.00197	CcSEcCtD
Lubiprostone—Syncope—Betamethasone—multiple sclerosis	0.0016	0.00197	CcSEcCtD
Lubiprostone—Shock—Triamcinolone—multiple sclerosis	0.00158	0.00195	CcSEcCtD
Lubiprostone—Shock—Methylprednisolone—multiple sclerosis	0.00158	0.00194	CcSEcCtD
Lubiprostone—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00157	0.00194	CcSEcCtD
Lubiprostone—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00157	0.00193	CcSEcCtD
Lubiprostone—Loss of consciousness—Betamethasone—multiple sclerosis	0.00157	0.00193	CcSEcCtD
Lubiprostone—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00157	0.00193	CcSEcCtD
Lubiprostone—Tachycardia—Triamcinolone—multiple sclerosis	0.00157	0.00193	CcSEcCtD
Lubiprostone—Mental disorder—Prednisone—multiple sclerosis	0.00157	0.00193	CcSEcCtD
Lubiprostone—Nausea—Azathioprine—multiple sclerosis	0.00157	0.00193	CcSEcCtD
Lubiprostone—Tachycardia—Methylprednisolone—multiple sclerosis	0.00156	0.00193	CcSEcCtD
Lubiprostone—Skin disorder—Methylprednisolone—multiple sclerosis	0.00156	0.00192	CcSEcCtD
Lubiprostone—Erythema—Prednisone—multiple sclerosis	0.00156	0.00192	CcSEcCtD
Lubiprostone—Malnutrition—Prednisone—multiple sclerosis	0.00156	0.00192	CcSEcCtD
Lubiprostone—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00155	0.00191	CcSEcCtD
Lubiprostone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00155	0.00191	CcSEcCtD
Lubiprostone—Asthenia—Mitoxantrone—multiple sclerosis	0.00153	0.00188	CcSEcCtD
Lubiprostone—Myalgia—Betamethasone—multiple sclerosis	0.00152	0.00187	CcSEcCtD
Lubiprostone—Myalgia—Dexamethasone—multiple sclerosis	0.00152	0.00187	CcSEcCtD
Lubiprostone—Anxiety—Betamethasone—multiple sclerosis	0.00152	0.00187	CcSEcCtD
Lubiprostone—Anxiety—Dexamethasone—multiple sclerosis	0.00152	0.00187	CcSEcCtD
Lubiprostone—Discomfort—Dexamethasone—multiple sclerosis	0.0015	0.00185	CcSEcCtD
Lubiprostone—Discomfort—Betamethasone—multiple sclerosis	0.0015	0.00185	CcSEcCtD
Lubiprostone—Pain—Prednisolone—multiple sclerosis	0.00149	0.00184	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00146	0.0018	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00146	0.0018	CcSEcCtD
Lubiprostone—Oedema—Betamethasone—multiple sclerosis	0.00146	0.0018	CcSEcCtD
Lubiprostone—Oedema—Dexamethasone—multiple sclerosis	0.00146	0.0018	CcSEcCtD
Lubiprostone—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00146	0.0018	CcSEcCtD
Lubiprostone—Ill-defined disorder—Prednisone—multiple sclerosis	0.00144	0.00178	CcSEcCtD
Lubiprostone—Feeling abnormal—Prednisolone—multiple sclerosis	0.00144	0.00177	CcSEcCtD
Lubiprostone—Shock—Dexamethasone—multiple sclerosis	0.00143	0.00177	CcSEcCtD
Lubiprostone—Shock—Betamethasone—multiple sclerosis	0.00143	0.00177	CcSEcCtD
Lubiprostone—Dyspnoea—Triamcinolone—multiple sclerosis	0.00143	0.00176	CcSEcCtD
Lubiprostone—Nervous system disorder—Betamethasone—multiple sclerosis	0.00143	0.00176	CcSEcCtD
Lubiprostone—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00143	0.00176	CcSEcCtD
Lubiprostone—Tachycardia—Betamethasone—multiple sclerosis	0.00142	0.00175	CcSEcCtD
Lubiprostone—Tachycardia—Dexamethasone—multiple sclerosis	0.00142	0.00175	CcSEcCtD
Lubiprostone—Dyspepsia—Triamcinolone—multiple sclerosis	0.00141	0.00174	CcSEcCtD
Lubiprostone—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00141	0.00174	CcSEcCtD
Lubiprostone—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00141	0.00174	CcSEcCtD
Lubiprostone—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00141	0.00174	CcSEcCtD
Lubiprostone—Malaise—Prednisone—multiple sclerosis	0.0014	0.00173	CcSEcCtD
Lubiprostone—Syncope—Prednisone—multiple sclerosis	0.0014	0.00172	CcSEcCtD
Lubiprostone—Anorexia—Betamethasone—multiple sclerosis	0.00139	0.00171	CcSEcCtD
Lubiprostone—Anorexia—Dexamethasone—multiple sclerosis	0.00139	0.00171	CcSEcCtD
Lubiprostone—Fatigue—Triamcinolone—multiple sclerosis	0.00139	0.00171	CcSEcCtD
Lubiprostone—Fatigue—Methylprednisolone—multiple sclerosis	0.00138	0.0017	CcSEcCtD
Lubiprostone—Pain—Triamcinolone—multiple sclerosis	0.00137	0.00169	CcSEcCtD
Lubiprostone—Loss of consciousness—Prednisone—multiple sclerosis	0.00137	0.00168	CcSEcCtD
Lubiprostone—Vomiting—Mitoxantrone—multiple sclerosis	0.00135	0.00167	CcSEcCtD
Lubiprostone—Mediastinal disorder—Methotrexate—multiple sclerosis	0.00135	0.00166	CcSEcCtD
Lubiprostone—Rash—Mitoxantrone—multiple sclerosis	0.00134	0.00165	CcSEcCtD
Lubiprostone—Dermatitis—Mitoxantrone—multiple sclerosis	0.00134	0.00165	CcSEcCtD
Lubiprostone—Headache—Mitoxantrone—multiple sclerosis	0.00133	0.00164	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00133	0.00164	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00133	0.00164	CcSEcCtD
Lubiprostone—Myalgia—Prednisone—multiple sclerosis	0.00132	0.00163	CcSEcCtD
Lubiprostone—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00132	0.00163	CcSEcCtD
Lubiprostone—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00132	0.00163	CcSEcCtD
Lubiprostone—Anxiety—Prednisone—multiple sclerosis	0.00132	0.00163	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00132	0.00162	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00131	0.00161	CcSEcCtD
Lubiprostone—Discomfort—Prednisone—multiple sclerosis	0.00131	0.00161	CcSEcCtD
Lubiprostone—Mental disorder—Methotrexate—multiple sclerosis	0.00131	0.00161	CcSEcCtD
Lubiprostone—Erythema—Methotrexate—multiple sclerosis	0.0013	0.0016	CcSEcCtD
Lubiprostone—Malnutrition—Methotrexate—multiple sclerosis	0.0013	0.0016	CcSEcCtD
Lubiprostone—Hypersensitivity—Prednisolone—multiple sclerosis	0.00129	0.00159	CcSEcCtD
Lubiprostone—Dyspepsia—Dexamethasone—multiple sclerosis	0.00128	0.00158	CcSEcCtD
Lubiprostone—Dyspepsia—Betamethasone—multiple sclerosis	0.00128	0.00158	CcSEcCtD
Lubiprostone—Dysgeusia—Methotrexate—multiple sclerosis	0.00127	0.00157	CcSEcCtD
Lubiprostone—Oedema—Prednisone—multiple sclerosis	0.00127	0.00156	CcSEcCtD
Lubiprostone—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00127	0.00156	CcSEcCtD
Lubiprostone—Decreased appetite—Dexamethasone—multiple sclerosis	0.00127	0.00156	CcSEcCtD
Lubiprostone—Decreased appetite—Betamethasone—multiple sclerosis	0.00127	0.00156	CcSEcCtD
Lubiprostone—Nausea—Mitoxantrone—multiple sclerosis	0.00127	0.00156	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00126	0.00155	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00126	0.00155	CcSEcCtD
Lubiprostone—Fatigue—Betamethasone—multiple sclerosis	0.00126	0.00155	CcSEcCtD
Lubiprostone—Fatigue—Dexamethasone—multiple sclerosis	0.00126	0.00155	CcSEcCtD
Lubiprostone—Shock—Prednisone—multiple sclerosis	0.00125	0.00154	CcSEcCtD
Lubiprostone—Pain—Dexamethasone—multiple sclerosis	0.00125	0.00154	CcSEcCtD
Lubiprostone—Pain—Betamethasone—multiple sclerosis	0.00125	0.00154	CcSEcCtD
Lubiprostone—Nervous system disorder—Prednisone—multiple sclerosis	0.00125	0.00153	CcSEcCtD
Lubiprostone—Tachycardia—Prednisone—multiple sclerosis	0.00124	0.00153	CcSEcCtD
Lubiprostone—Skin disorder—Prednisone—multiple sclerosis	0.00123	0.00152	CcSEcCtD
Lubiprostone—Hyperhidrosis—Prednisone—multiple sclerosis	0.00123	0.00151	CcSEcCtD
Lubiprostone—Anorexia—Prednisone—multiple sclerosis	0.00121	0.00149	CcSEcCtD
Lubiprostone—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00121	0.00149	CcSEcCtD
Lubiprostone—Feeling abnormal—Betamethasone—multiple sclerosis	0.0012	0.00148	CcSEcCtD
Lubiprostone—Feeling abnormal—Dexamethasone—multiple sclerosis	0.0012	0.00148	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00119	0.00147	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00119	0.00147	CcSEcCtD
Lubiprostone—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00118	0.00146	CcSEcCtD
Lubiprostone—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00118	0.00146	CcSEcCtD
Lubiprostone—Malaise—Methotrexate—multiple sclerosis	0.00117	0.00144	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00116	0.00142	CcSEcCtD
Lubiprostone—Dizziness—Prednisolone—multiple sclerosis	0.00116	0.00142	CcSEcCtD
Lubiprostone—Asthenia—Triamcinolone—multiple sclerosis	0.00115	0.00142	CcSEcCtD
Lubiprostone—Abdominal pain—Betamethasone—multiple sclerosis	0.00115	0.00142	CcSEcCtD
Lubiprostone—Abdominal pain—Dexamethasone—multiple sclerosis	0.00115	0.00142	CcSEcCtD
Lubiprostone—Asthenia—Methylprednisolone—multiple sclerosis	0.00115	0.00142	CcSEcCtD
Lubiprostone—Cough—Methotrexate—multiple sclerosis	0.00113	0.0014	CcSEcCtD
Lubiprostone—Dyspepsia—Prednisone—multiple sclerosis	0.00112	0.00138	CcSEcCtD
Lubiprostone—Chest pain—Methotrexate—multiple sclerosis	0.00111	0.00136	CcSEcCtD
Lubiprostone—Myalgia—Methotrexate—multiple sclerosis	0.00111	0.00136	CcSEcCtD
Lubiprostone—Decreased appetite—Prednisone—multiple sclerosis	0.0011	0.00136	CcSEcCtD
Lubiprostone—Rash—Prednisolone—multiple sclerosis	0.0011	0.00136	CcSEcCtD
Lubiprostone—Dermatitis—Prednisolone—multiple sclerosis	0.0011	0.00136	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.0011	0.00135	CcSEcCtD
Lubiprostone—Diarrhoea—Methylprednisolone—multiple sclerosis	0.0011	0.00135	CcSEcCtD
Lubiprostone—Fatigue—Prednisone—multiple sclerosis	0.00109	0.00135	CcSEcCtD
Lubiprostone—Headache—Prednisolone—multiple sclerosis	0.00109	0.00135	CcSEcCtD
Lubiprostone—Discomfort—Methotrexate—multiple sclerosis	0.00109	0.00135	CcSEcCtD
Lubiprostone—Constipation—Prednisone—multiple sclerosis	0.00109	0.00134	CcSEcCtD
Lubiprostone—Dizziness—Triamcinolone—multiple sclerosis	0.00106	0.00131	CcSEcCtD
Lubiprostone—Dizziness—Methylprednisolone—multiple sclerosis	0.00106	0.00131	CcSEcCtD
Lubiprostone—Feeling abnormal—Prednisone—multiple sclerosis	0.00105	0.00129	CcSEcCtD
Lubiprostone—Asthenia—Betamethasone—multiple sclerosis	0.00105	0.00129	CcSEcCtD
Lubiprostone—Asthenia—Dexamethasone—multiple sclerosis	0.00105	0.00129	CcSEcCtD
Lubiprostone—Nervous system disorder—Methotrexate—multiple sclerosis	0.00104	0.00128	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00104	0.00128	CcSEcCtD
Lubiprostone—Nausea—Prednisolone—multiple sclerosis	0.00104	0.00128	CcSEcCtD
Lubiprostone—Skin disorder—Methotrexate—multiple sclerosis	0.00103	0.00127	CcSEcCtD
Lubiprostone—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00103	0.00126	CcSEcCtD
Lubiprostone—Vomiting—Triamcinolone—multiple sclerosis	0.00102	0.00126	CcSEcCtD
Lubiprostone—Vomiting—Methylprednisolone—multiple sclerosis	0.00102	0.00126	CcSEcCtD
Lubiprostone—Rash—Triamcinolone—multiple sclerosis	0.00101	0.00125	CcSEcCtD
Lubiprostone—Dermatitis—Triamcinolone—multiple sclerosis	0.00101	0.00125	CcSEcCtD
Lubiprostone—Anorexia—Methotrexate—multiple sclerosis	0.00101	0.00125	CcSEcCtD
Lubiprostone—Rash—Methylprednisolone—multiple sclerosis	0.00101	0.00125	CcSEcCtD
Lubiprostone—Dermatitis—Methylprednisolone—multiple sclerosis	0.00101	0.00124	CcSEcCtD
Lubiprostone—Headache—Triamcinolone—multiple sclerosis	0.00101	0.00124	CcSEcCtD
Lubiprostone—Headache—Methylprednisolone—multiple sclerosis	0.001	0.00124	CcSEcCtD
Lubiprostone—Abdominal pain—Prednisone—multiple sclerosis	0.001	0.00124	CcSEcCtD
Lubiprostone—Diarrhoea—Betamethasone—multiple sclerosis	0.000998	0.00123	CcSEcCtD
Lubiprostone—Diarrhoea—Dexamethasone—multiple sclerosis	0.000998	0.00123	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000967	0.00119	CcSEcCtD
Lubiprostone—Dizziness—Betamethasone—multiple sclerosis	0.000964	0.00119	CcSEcCtD
Lubiprostone—Dizziness—Dexamethasone—multiple sclerosis	0.000964	0.00119	CcSEcCtD
Lubiprostone—Nausea—Triamcinolone—multiple sclerosis	0.000955	0.00118	CcSEcCtD
Lubiprostone—Nausea—Methylprednisolone—multiple sclerosis	0.000952	0.00117	CcSEcCtD
Lubiprostone—Dyspnoea—Methotrexate—multiple sclerosis	0.000946	0.00117	CcSEcCtD
Lubiprostone—Hypersensitivity—Prednisone—multiple sclerosis	0.000936	0.00115	CcSEcCtD
Lubiprostone—Dyspepsia—Methotrexate—multiple sclerosis	0.000934	0.00115	CcSEcCtD
Lubiprostone—Vomiting—Betamethasone—multiple sclerosis	0.000927	0.00114	CcSEcCtD
Lubiprostone—Vomiting—Dexamethasone—multiple sclerosis	0.000927	0.00114	CcSEcCtD
Lubiprostone—Decreased appetite—Methotrexate—multiple sclerosis	0.000922	0.00114	CcSEcCtD
Lubiprostone—Rash—Betamethasone—multiple sclerosis	0.000919	0.00113	CcSEcCtD
Lubiprostone—Rash—Dexamethasone—multiple sclerosis	0.000919	0.00113	CcSEcCtD
Lubiprostone—Dermatitis—Dexamethasone—multiple sclerosis	0.000918	0.00113	CcSEcCtD
Lubiprostone—Dermatitis—Betamethasone—multiple sclerosis	0.000918	0.00113	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000916	0.00113	CcSEcCtD
Lubiprostone—Fatigue—Methotrexate—multiple sclerosis	0.000915	0.00113	CcSEcCtD
Lubiprostone—Headache—Dexamethasone—multiple sclerosis	0.000913	0.00113	CcSEcCtD
Lubiprostone—Headache—Betamethasone—multiple sclerosis	0.000913	0.00113	CcSEcCtD
Lubiprostone—Asthenia—Prednisone—multiple sclerosis	0.000911	0.00112	CcSEcCtD
Lubiprostone—Pain—Methotrexate—multiple sclerosis	0.000907	0.00112	CcSEcCtD
Lubiprostone—Feeling abnormal—Methotrexate—multiple sclerosis	0.000874	0.00108	CcSEcCtD
Lubiprostone—Diarrhoea—Prednisone—multiple sclerosis	0.000869	0.00107	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000868	0.00107	CcSEcCtD
Lubiprostone—Nausea—Betamethasone—multiple sclerosis	0.000866	0.00107	CcSEcCtD
Lubiprostone—Nausea—Dexamethasone—multiple sclerosis	0.000866	0.00107	CcSEcCtD
Lubiprostone—Dizziness—Prednisone—multiple sclerosis	0.00084	0.00103	CcSEcCtD
Lubiprostone—Abdominal pain—Methotrexate—multiple sclerosis	0.000839	0.00103	CcSEcCtD
Lubiprostone—Vomiting—Prednisone—multiple sclerosis	0.000807	0.000994	CcSEcCtD
Lubiprostone—Rash—Prednisone—multiple sclerosis	0.000801	0.000986	CcSEcCtD
Lubiprostone—Dermatitis—Prednisone—multiple sclerosis	0.0008	0.000985	CcSEcCtD
Lubiprostone—Headache—Prednisone—multiple sclerosis	0.000795	0.00098	CcSEcCtD
Lubiprostone—Hypersensitivity—Methotrexate—multiple sclerosis	0.000782	0.000963	CcSEcCtD
Lubiprostone—Asthenia—Methotrexate—multiple sclerosis	0.000761	0.000938	CcSEcCtD
Lubiprostone—Nausea—Prednisone—multiple sclerosis	0.000754	0.000929	CcSEcCtD
Lubiprostone—Diarrhoea—Methotrexate—multiple sclerosis	0.000726	0.000894	CcSEcCtD
Lubiprostone—Dizziness—Methotrexate—multiple sclerosis	0.000702	0.000864	CcSEcCtD
Lubiprostone—Vomiting—Methotrexate—multiple sclerosis	0.000675	0.000831	CcSEcCtD
Lubiprostone—Rash—Methotrexate—multiple sclerosis	0.000669	0.000824	CcSEcCtD
Lubiprostone—Dermatitis—Methotrexate—multiple sclerosis	0.000668	0.000823	CcSEcCtD
Lubiprostone—Headache—Methotrexate—multiple sclerosis	0.000665	0.000819	CcSEcCtD
Lubiprostone—Nausea—Methotrexate—multiple sclerosis	0.00063	0.000776	CcSEcCtD
